Gardasil
E468956
Gardasil is a widely used human papillomavirus (HPV) vaccine that helps prevent cervical and other HPV-related cancers and diseases.
Observed surface forms (2)
| Surface form | Occurrences |
|---|---|
| Gardasil 9 | 1 |
| human papillomavirus | 1 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
human papillomavirus vaccine
ⓘ
prophylactic vaccine ⓘ vaccine ⓘ |
| administrationSetting |
clinics
ⓘ
hospitals ⓘ public health vaccination centers ⓘ |
| ageGroup |
primarily adolescents
ⓘ
young adults ⓘ |
| approvedBy | U.S. Food and Drug Administration NERFINISHED ⓘ |
| belongsTo | HPV vaccination programs ⓘ |
| contains |
HPV L1 virus-like particles
ⓘ
aluminum-containing adjuvant ⓘ |
| developedBy | Merck & Co. NERFINISHED ⓘ |
| doesNotContain |
HPV DNA capable of infection
ⓘ
live virus ⓘ |
| Gardasil9Targets | nine HPV types including 6, 11, 16, 18 ⓘ |
| hasGenericName | quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine NERFINISHED ⓘ |
| hasTradeName | Silgard NERFINISHED ⓘ |
| indicatedFor |
prevention of HPV-related diseases
ⓘ
use in females ⓘ use in males ⓘ |
| initialFDAApprovalYear | 2006 ⓘ |
| isDifferentFrom | Gardasil 9 NERFINISHED ⓘ |
| marketedAs | Silgard in some countries ⓘ |
| prevents |
HPV-related precancerous lesions
ⓘ
anal cancer caused by HPV ⓘ cervical cancer caused by HPV types 16 and 18 ⓘ cervical intraepithelial neoplasia ⓘ genital warts caused by HPV types 6 and 11 ⓘ vaginal cancer caused by HPV ⓘ vaginal intraepithelial neoplasia ⓘ vulvar cancer caused by HPV ⓘ vulvar intraepithelial neoplasia ⓘ |
| publicHealthRole |
reducing incidence of cervical cancer
ⓘ
reducing incidence of genital warts ⓘ |
| recommendedBy |
Advisory Committee on Immunization Practices
NERFINISHED
ⓘ
World Health Organization NERFINISHED ⓘ |
| routeOfAdministration | intramuscular injection ⓘ |
| storageCondition | refrigerated ⓘ |
| targets |
human papillomavirus type 11
NERFINISHED
ⓘ
human papillomavirus type 16 NERFINISHED ⓘ human papillomavirus type 18 NERFINISHED ⓘ human papillomavirus type 6 NERFINISHED ⓘ |
| type | quadrivalent HPV vaccine ⓘ |
| typicalInjectionSite | deltoid muscle ⓘ |
| typicalSchedule |
2-dose schedule for younger adolescents
ⓘ
3-dose schedule for older adolescents and adults ⓘ |
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Gardasil 9
this entity surface form:
human papillomavirus